Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 42

1.

Adolescent attachment insecurity and the influence of MBT.

Hauber K, Boon A, Kuipers G, Vermeiren R.

Attach Hum Dev. 2018 Oct 5:1-17. doi: 10.1080/14616734.2018.1529808. [Epub ahead of print]

PMID:
30289051
2.

Determinants of full vaccination status in children aged 12-23 months in Gurùé and Milange districts, Mozambique: results of a population-based cross-sectional survey.

Shemwell SA, Peratikos MB, González-Calvo L, Renom-Llonch M, Boon A, Martinho S, Cherry CB, Green AF, Moon TD.

Int Health. 2017 Jul 1;9(4):234-242. doi: 10.1093/inthealth/ihx020.

3.

The neural correlates of childhood maltreatment and the ability to understand mental states of others.

van Schie CC, van Harmelen AL, Hauber K, Boon A, Crone EA, Elzinga BM.

Eur J Psychotraumatol. 2017 Feb 9;8(1):1272788. doi: 10.1080/20008198.2016.1272788. eCollection 2017.

4.

Muscle ultrasound.

Pillen S, Boon A, Van Alfen N.

Handb Clin Neurol. 2016;136:843-53. doi: 10.1016/B978-0-444-53486-6.00042-9. Review.

PMID:
27430445
5.

Lessons learned from early implementation of option B+: the Elizabeth Glaser Pediatric AIDS Foundation experience in 11 African countries.

Kieffer MP, Mattingly M, Giphart A, van de Ven R, Chouraya C, Walakira M, Boon A, Mikusova S, Simonds RJ; EGPAF Technical Directors Forum.

J Acquir Immune Defic Syndr. 2014 Dec 1;67 Suppl 4:S188-94. doi: 10.1097/QAI.0000000000000372. Review.

6.

The clinicopathological and gene expression patterns associated with ulceration of primary melanoma.

Jewell R, Elliott F, Laye J, Nsengimana J, Davies J, Walker C, Conway C, Mitra A, Harland M, Cook MG, Boon A, Storr S, Safuan S, Martin SG, Jirström K, Olsson H, Ingvar C, Lauss M, Bishop T, Jönsson G, Newton-Bishop J.

Pigment Cell Melanoma Res. 2015 Jan;28(1):94-104. doi: 10.1111/pcmr.12315. Epub 2014 Oct 1.

7.

An exploration of reported mortality from cutaneous squamous cell carcinoma using death certification and cancer registry data.

Rose RF, Boon A, Forman D, Merchant W, Bishop R, Newton-Bishop JA.

Br J Dermatol. 2013 Sep;169(3):682-6. doi: 10.1111/bjd.12388.

PMID:
23600487
8.

Ultrasonography and electrodiagnosis: are they complementary techniques?

Boon A.

PM R. 2013 May;5(5 Suppl):S100-6. doi: 10.1016/j.pmrj.2013.03.014. Epub 2013 Mar 19. Review.

PMID:
23524068
9.

Clinicopathologic features of V600E and V600K melanoma--letter.

Jewell R, Chambers P, Harland M, Laye J, Conway C, Mitra A, Elliott F, Cook MG, Boon A, Newton-Bishop J.

Clin Cancer Res. 2012 Dec 15;18(24):6792; author's reply p. 6793. doi: 10.1158/1078-0432.CCR-12-2974. Epub 2012 Nov 20. No abstract available.

10.

[Reaction on 'Contact with the child and adolescent psychiatric services is determined by cultural and socio-economic differences'].

Boon A, de Haan A, de Boer S.

Tijdschr Psychiatr. 2012;54(1):101-2; author reply 102-3. Dutch. No abstract available.

11.

Identification of differentially expressed genes in matched formalin-fixed paraffin-embedded primary and metastatic melanoma tumor pairs.

Jewell R, Mitra A, Conway C, Iremonger J, Walker C, de Kort F, Cook M, Boon A, Speirs V, Newton-Bishop J.

Pigment Cell Melanoma Res. 2012 Mar;25(2):284-6. doi: 10.1111/j.1755-148X.2011.00965.x. Epub 2012 Jan 13. No abstract available.

PMID:
22212396
12.

Patterns of expression of DNA repair genes and relapse from melanoma.

Jewell R, Conway C, Mitra A, Randerson-Moor J, Lobo S, Nsengimana J, Harland M, Marples M, Edward S, Cook M, Powell B, Boon A, de Kort F, Parker KA, Cree IA, Barrett JH, Knowles MA, Bishop DT, Newton-Bishop J.

Clin Cancer Res. 2010 Nov 1;16(21):5211-21. doi: 10.1158/1078-0432.CCR-10-1521. Epub 2010 Aug 12.

13.

Deletion at chromosome arm 9p in relation to BRAF/NRAS mutations and prognostic significance for primary melanoma.

Conway C, Beswick S, Elliott F, Chang YM, Randerson-Moor J, Harland M, Affleck P, Marsden J, Sanders DS, Boon A, Knowles MA, Bishop DT, Newton-Bishop JA.

Genes Chromosomes Cancer. 2010 May;49(5):425-38. doi: 10.1002/gcc.20753.

14.

Gene expression profiling of paraffin-embedded primary melanoma using the DASL assay identifies increased osteopontin expression as predictive of reduced relapse-free survival.

Conway C, Mitra A, Jewell R, Randerson-Moor J, Lobo S, Nsengimana J, Edward S, Sanders DS, Cook M, Powell B, Boon A, Elliott F, de Kort F, Knowles MA, Bishop DT, Newton-Bishop J.

Clin Cancer Res. 2009 Nov 15;15(22):6939-46. doi: 10.1158/1078-0432.CCR-09-1631. Epub 2009 Nov 3.

15.

Metastatic malignant melanoma of the conjunctiva: a case report.

Manidakis N, Polyzois I, Tsialogiannis E, Marples M, Boon A, Tsiridis E.

Cases J. 2009 Feb 4;2(1):125. doi: 10.1186/1757-1626-2-125.

16.

Environmental risk factors for relapse of melanoma.

Beswick S, Affleck P, Elliott F, Gerry E, Boon A, Bale L, Nolan C, Barrett JH, Bertram C, Marsden J, Bishop DT, Newton-Bishop JA.

Eur J Cancer. 2008 Aug;44(12):1717-25. doi: 10.1016/j.ejca.2008.05.007. Epub 2008 Jul 2.

17.

Response to: 'Malignant melanoma re-excision specimens: is there a need for histopathological analysis?' McGoldrick et al., J PRAS 2008; 61:983-984.

Boon A.

J Plast Reconstr Aesthet Surg. 2008 Oct;61(10):1246. doi: 10.1016/j.bjps.2007.10.058. Epub 2008 Apr 14. No abstract available.

PMID:
18407816
18.

Cryptic mosaicism for monosomy 20 identified in renal tract cells.

Stefanou EG, Crocker M, Boon A, Stewart H.

Clin Genet. 2006 Sep;70(3):228-32.

PMID:
16922725
19.

Fatal haemothorax following large-bore percutaneous cannulation before liver transplantation.

Jankovic Z, Boon A, Prasad R.

Br J Anaesth. 2005 Oct;95(4):472-6. Epub 2005 Aug 5.

20.

Cutaneous granulomas associated with primary immunodeficiency disorders.

Mitra A, Pollock B, Gooi J, Darling JC, Boon A, Newton-Bishop JA.

Br J Dermatol. 2005 Jul;153(1):194-9.

PMID:
16029350

Supplemental Content

Loading ...
Support Center